SI1052973T1 - Transmucosal formulations of levosimendan - Google Patents
Transmucosal formulations of levosimendanInfo
- Publication number
- SI1052973T1 SI1052973T1 SI9830182T SI9830182T SI1052973T1 SI 1052973 T1 SI1052973 T1 SI 1052973T1 SI 9830182 T SI9830182 T SI 9830182T SI 9830182 T SI9830182 T SI 9830182T SI 1052973 T1 SI1052973 T1 SI 1052973T1
- Authority
- SI
- Slovenia
- Prior art keywords
- levosimendan
- transmucosal formulations
- transmucosal
- formulations
- Prior art date
Links
- 238000009472 formulation Methods 0.000 title 1
- WHXMKTBCFHIYNQ-SECBINFHSA-N levosimendan Chemical compound C[C@@H]1CC(=O)NN=C1C1=CC=C(NN=C(C#N)C#N)C=C1 WHXMKTBCFHIYNQ-SECBINFHSA-N 0.000 title 1
- 229960000692 levosimendan Drugs 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FI974578A FI974578L (en) | 1997-12-19 | 1997-12-19 | Method of administration of levosimendan |
| PCT/FI1998/000977 WO1999032081A1 (en) | 1997-12-19 | 1998-12-11 | Transmucosal formulations of levosimendan |
| EP98959930A EP1052973B1 (en) | 1997-12-19 | 1998-12-11 | Transmucosal formulations of levosimendan |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SI1052973T1 true SI1052973T1 (en) | 2002-08-31 |
Family
ID=26152791
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SI9830182T SI1052973T1 (en) | 1997-12-19 | 1998-12-11 | Transmucosal formulations of levosimendan |
Country Status (1)
| Country | Link |
|---|---|
| SI (1) | SI1052973T1 (en) |
-
1998
- 1998-12-11 SI SI9830182T patent/SI1052973T1/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB9715751D0 (en) | Formulations | |
| PL343021A1 (en) | Formulations | |
| EP1020193A4 (en) | Oral preparation | |
| PL339864A1 (en) | Preparation containing 2-methylthiene benzodiazepin | |
| IL134802A0 (en) | Oral compositions of levosimendan | |
| GB2323531B (en) | Therapeutic formulations | |
| GB9715446D0 (en) | Glazes | |
| HUP0100452A3 (en) | Transmucosal formulations of levosimendan | |
| CY2590B2 (en) | Preparation of 1-butyl-4-piperidinylmethylamine | |
| GB9806312D0 (en) | Novel formulations | |
| GB9815002D0 (en) | Formulations | |
| HUP9902855A3 (en) | Preparation of sterol- and stanol-esters | |
| GB9815001D0 (en) | Formulations | |
| GB9810181D0 (en) | Novel formulations | |
| GB9605948D0 (en) | Novel formulations | |
| SI1052973T1 (en) | Transmucosal formulations of levosimendan | |
| IL124387A0 (en) | Preparation of 5-Methyleneoxazolines | |
| GB2329384B (en) | Preparation of 1-chloro-1-cyclopropylethene | |
| PL327430A1 (en) | Set of shaped components | |
| GB9703100D0 (en) | Formulations | |
| GB9703101D0 (en) | Formulations | |
| GB9703099D0 (en) | Formulations | |
| GB9704521D0 (en) | Formulations | |
| TW312301U (en) | Improved structure of earmask | |
| TW319017U (en) | Improved structure of mousetraps |